Target intelligence / Profile preview

Non-LYN mRNAs with seed-region complementarity

Molecular classification
Messenger RNA
01

Overview

Non-LYN mRNAs with seed-region complementarity refers to a collection of unintended messenger RNA transcripts that are downregulated by RNA interference (RNAi) molecules originally designed to target the LYN kinase. This off-target effect occurs when the seed region of an siRNA or shRNA—typically nucleotides 2 through 7 or 8—binds to complementary sequences in the 3' untranslated regions (UTRs) of non-target mRNAs (Jackson et al., 2003, Nature Biotechnology). This binding mimics the natural regulatory mechanism of microRNAs, leading to the degradation or translational inhibition of these unintended transcripts (Birmingham et al., 2006, Nature Methods). In many instances, these off-target interactions can lead to significant cellular toxicity, a phenomenon termed Death Induced by Survival gene Elimination (DISE), where the simultaneous knockdown of multiple essential survival genes triggers apoptosis (Putzbach et al., 2017, eLife). This is particularly relevant in cancer research, where LYN-targeting siRNAs may appear to have therapeutic efficacy that is actually driven by these non-specific seed-mediated effects. Consequently, these mRNAs represent a major safety concern and a technical challenge in the development of RNAi-based therapeutics, requiring careful sequence design and chemical modifications to minimize unintended gene silencing.

Other names
Off-target mRNAsSeed-matched transcriptsRNAi off-targets6mer seed-matched targets
02

Mechanism of action

Seed-mediated RNA interference (RNAi) leading to unintended transcript degradation or translational repression.

03

Biological functions

Protein translationGene expression regulation
04

Disease associations

Off-target toxicityCell death
05

Safety considerations

Off-target toxicityDeath Induced by Survival gene Elimination (DISE)Non-specific gene silencingConfounding experimental results
06

Interacting drugs

LYN-targeting siRNAs

1 more in the full profile.

Beyond the preview

Go deeper on Non-LYN mRNAs with seed-region complementarity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Non-LYN mRNAs with seed-region complementarity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call